Nuveen Asset Management, LLC Insmed Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 537,231 shares of INSM stock, worth $33.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

537,231

Previous 377,215 42.42%

Holding current value

$33.3 Million

Previous $11.7 Million 24.69%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $4.12 Million - $4.79 Million	160,016 Added 42.42%	537,231 $14.6 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $666,275 - $902,971	28,449 Added 8.16%	377,215 $11.7 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $140,529 - $190,556	-7,076 Reduced 1.99%	348,766 $8.81 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $31,745 - $40,744	1,931 Added 0.55%	355,842 $7.51 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $11.4 Million - $15.3 Million	-702,679 Reduced 66.5%	353,911 $6.03 Million

Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $3.95 Million - $5.38 Million	232,374 Added 28.19%	1,056,590 $21.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $7.16 Million - $9.67 Million	342,694 Added 71.17%	824,216 $17.8 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $401,981 - $605,444	-23,549 Reduced 4.66%	481,522 $9.5 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $12,803 - $17,637	627 Added 0.12%	505,071 $11.7 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $793,010 - $1.02 Million	-30,630 Reduced 5.72%	504,444 $13.3 Million
Q3 2021 Nov 12, 2021	SELL	$22.46 - $29.47 $657,718 - $862,999	-29,284 Reduced 5.19%	535,074 $14.3 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $62,141 - $92,581	2,571 Added 0.46%	564,358 $16.1 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $1.3 Million - $1.78 Million	-40,206 Reduced 6.68%	561,787 $19.1 Million
Q4 2020 May 17, 2021	SELL	$31.45 - $40.54 $970,326 - $1.25 Million	-30,853 Reduced 4.88%	601,993 $20 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $2.94 Million - $3.79 Million	93,595 Added 17.36%	632,846 $21.1 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $938,002 - $1.24 Million	-36,077 Reduced 6.27%	539,251 $17.3 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $323,034 - $673,541	22,894 Added 4.14%	575,328 $15.8 Million
Q1 2020 May 14, 2020	SELL	$13.63 - $33.98 $431,771 - $1.08 Million	-31,678 Reduced 5.42%	552,434 $8.86 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $1.84 Million - $2.85 Million	114,232 Added 24.31%	584,112 $13.9 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $1.08 Million - $1.8 Million	69,837 Added 17.46%	469,880 $8.29 Million
Q2 2019 Aug 15, 2019	BUY	$23.0 - $32.19 $9.2 Million - $12.9 Million	400,043 New	400,043 $10.2 Million

Others Institutions Holding INSM

# of Institutions

340

Shares Held

141M

Call Options Held

2.25M

Put Options Held

3.11M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.4B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Insmed Inc Transaction History